Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06037603 · ClinicalTrials.gov registry record · NA
Dual-Task Exercise for Mild Traumatic Brain Injury (mTBI)
A NA study, sponsored by University of Nevada, Las Vegas.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT06037603: Completed NA study, sponsored by University of Nevada, Las Vegas.
NCT06037603 is a NA study that has completed, run by University of Nevada, Las Vegas. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06037603, a NA study, has completed, sponsored by University of Nevada, Las Vegas.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The investigators previously developed a virtual 14-day dual-task walking exercise program and tested its feasibility with individuals with mild traumatic brain injury (mTBI) history. The investigators will test the feasibility and efficacy of a mobile app-version (Uplode) of the same 14-day exercise program (Brain \& Walk Exercise Every Day \[BraW-Day\]), on cognition, sensorimotor, and other functions in a group of voluntary young adults with an mTBI between last three months to two years, including student athletes, Veterans, and ethnic minorities.
Primary Outcome
The CNS-Vital Signs Test is a computerized test of cognitive functioning with good-to-excellent reliabilities (most r's \> 0.8) in its different sub-tests. It will measure comprehensive neurocognitive function, including memory, attention psychomotor speed, reaction time, and cognitive flexibility. Higher scores mean better cognitive functioning outcomes. The CNS-Vital Signs Test standard scores and percentile ranks are auto-scored using an algorithm based on a normative data set of 1600+ subjec
Interventions
- BEHAVIORAL Brain & Walk Exercise Every Day (BraW-Day)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2024-03-06 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
What the finished NCT06037603 record still lists
NCT06037603 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Brain & Walk Exercise Every Day (BraW-Day) is the first listed.
NCT06037603 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06037603 about?
NCT06037603 is a clinical study titled "Dual-Task Exercise for Mild Traumatic Brain Injury (mTBI)". The investigators previously developed a virtual 14-day dual-task walking exercise program and tested its feasibility with individuals with mild traumatic brain injury (mTBI) history. The investigators will test the feasibility and efficacy of a mobile app-version (Uplode) of the same 14-day exercis...
What is the current status of trial NCT06037603?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2024-03-06. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT06037603?
The interventions under investigation include: Brain & Walk Exercise Every Day (BraW-Day) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06037603?
This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06037603's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI